The rotating rodent: a two component system?
- PMID: 340238
- DOI: 10.1016/0014-2999(78)90388-6
The rotating rodent: a two component system?
Abstract
The hypothesis that the rotating rat requires both nigro-striatal and mesolimbic dopaminergic components for activity has been tested. 6-Hydroxydopamine lesions were induced unilaterally in either or both the ascending nigrostriatal and mesolimbic dopamine pathway. In one group of rats the nucleus accumbens was destroyed bilaterally with electrolesions. Circling behaviour was only recorded when there was both an imbalance in striatal dopamine concentrations concomitant with stimulation of the limbic dopamine regions. Lesions of the mesolimbic dopamine pathway resulted in changes in drug-induced motor activity but postural asymmetry or circling behaviour was not observed. The results support the hypothesis that the rotating rodent requires two functional dopamine components: striatal dopamine imbalance causing a postural asymmetry and stimulation of mesolimbic dopamine systems providing a locomotor component. The relevance of these components in this animal model is discussed with reference to dopaminergic agonist and antagonist drugs.
Similar articles
-
The relationship between striatal and mesolimbic dopamine dysfunction and the nature of circling responses following 6-hydroxydopamine and electrolytic lesions of the ascending dopamine systems of rat brain.Brain Res. 1976 Dec 10;118(1):87-113. doi: 10.1016/0006-8993(76)90843-x. Brain Res. 1976. PMID: 990957
-
Dopamine-mediated circling behaviour does not involve the nigro-tectal pathway.Exp Brain Res. 1979 Oct;37(2):309-16. doi: 10.1007/BF00237716. Exp Brain Res. 1979. PMID: 315328
-
Neuropharmacological studies on D145 (1,3-dimethyl-5-aminoadamantan).Psychopharmacologia. 1975 Jul 23;43(1):53-61. doi: 10.1007/BF00437615. Psychopharmacologia. 1975. PMID: 1099605
-
6-hydroxydopamine-induced degeneration of the nigrostriatal dopamine pathway: the turning syndrome.Pharmacol Ther B. 1976;2(1):37-40. doi: 10.1016/0306-039x(76)90016-7. Pharmacol Ther B. 1976. PMID: 772721 Review. No abstract available.
-
Antiparkinsonian drugs and dopaminergic neostriatal mechanisms: studies in rats with unilateral 6-hydroxydopamine (=6-OH-DA)-induced degeneration of the nigro-neostriatal DA pathway and quantitative recording of rotational behaviour.Pharmacol Ther B. 1976;2(1):41-7. doi: 10.1016/0306-039x(76)90017-9. Pharmacol Ther B. 1976. PMID: 817332 Review. No abstract available.
Cited by
-
Exploring neurocircuitries of the basal ganglia by intracerebral administration of selective neurotoxins.Neurotox Res. 2007 Apr;11(3-4):169-82. doi: 10.1007/BF03033566. Neurotox Res. 2007. PMID: 17449458 Review.
-
Role of globus pallidus GABA and opiate receptors in apomorphine circling in nigro-striatal lesioned rats.Naunyn Schmiedebergs Arch Pharmacol. 1982 Apr;319(1):43-7. doi: 10.1007/BF00491477. Naunyn Schmiedebergs Arch Pharmacol. 1982. PMID: 6287299
-
Effect of right middle cerebral artery occlusion on striatal dopaminergic function.J Neural Transm. 1982;53(4):257-64. doi: 10.1007/BF01252037. J Neural Transm. 1982. PMID: 7108507
-
GABAergic and glycinergic mechanisms within the substantia nigra: pharmacological specificity of dopamine-independent contralateral turning behavior and interactions with other neurotransmitters.Psychopharmacology (Berl). 1979 Apr 25;62(3):267-77. doi: 10.1007/BF00431958. Psychopharmacology (Berl). 1979. PMID: 37544
-
Substantia nigra as an out-put station for striatal dopaminergic responses: role of a GABA-mediated inhibition of pars reticulata neurons.Naunyn Schmiedebergs Arch Pharmacol. 1979 Mar;306(2):153-9. doi: 10.1007/BF00498985. Naunyn Schmiedebergs Arch Pharmacol. 1979. PMID: 571967
MeSH terms
Substances
LinkOut - more resources
Full Text Sources